Vendor Analysis
published on Sep 13, 2024
Report Overview:
This NelsonHall vendor assessment analyzes Apexon's offerings and capabilities in quality engineering services
Who is this Report for:
NelsonHall’s Quality Engineering profile on Apexon is a comprehensive assessment of Apexon’s offerings and capabilities, designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of QE and identifying vendor suitability for quality engineering/QA/testing services
- Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the QE and IT services sectors.
Scope of this Report:
The report provides a comprehensive and objective analysis of Apexon’s QE offerings, capabilities, and market and financial strengths, including:
- Identification of the company’s strategy, emphasis, and new developments
- Analysis of the company’s strengths, challenges, and outlook
- Revenue estimates
- Analysis of the company’s offerings and key service components
- Analysis of the company’s delivery organization, including the location of delivery centers.
Key Findings & Highlights:
Apexon is an IT service vendor backed by two PEs: Goldman Sachs and Everstone Capital. It has ~6.5k personnel. It primarily services BFSI, healthcare & life sciences (mainly healthcare payers and providers and expanding to pharma), and high-tech & manufacturing (primarily medical devices manufacturing and the U.S. midsized high-tech industry).
Apexon is active in three areas:
- Experience: UX and enterprise applications such as Salesforce, content management systems (CMS), and e-commerce
- Digital engineering, including cloud infrastructure services, RPA, product engineering, custom software development, and quality engineering
- Data & analytics, including data engineering, management and governance, AI, and visualization.
Apexon has a headcount of 6.5k, including 4.8k personnel in India, 1.5k in the Americas, and 200 in the U.K.
